CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
Stay updated with breaking news from Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...
Nothing says “Thank you for your service” like threatening to ruin your life for not taking an experimental vaccine.
A negative vote on one of its drugs is weighing on the biotech's stock price.
The mRNA vaccines were not a product of Operation Warp Speed and developed in just a few months -- rather, DARPA has been working on them with companies such as Moderna since 2011.
Investegate announcements from BioNTech SE, BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update